Could a Two-Drug combo stop repeat heart attacks?

This study tests whether adding a PCSK9 inhibitor (a powerful cholesterol-lowering drug) to high-intensity statin therapy can prevent future cardiovascular events in people who have recently had a heart attack or unstable angina and underwent a stent procedure. About 1,200 participants receive either the PCSK9 inhibitor or a placebo, plus a statin, and are followed for outcomes like heart attack, stroke, or rehospitalization. The goal is to see if the combination therapy reduces these risks more than statins alone.